PRIMARY STUDY
The pharmacology and therapeutic role of cannabidiol in diabetes
Key Findings: This review highlights cannabidiol’s multifaceted pharmacological potential in diabetes management, detailing its effects on complications such as cardiovascular disease, nephropathy, retinopathy, and neuropathy, while proposing molecular target discovery and structural optimization strategies for novel CBD-based therapeutics.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Australia, China
Year of Pub: 2025
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Not Applicable
Chemotype: , Chemotype III
Citation: Zhang J, Lin C, Jin S, Wang H, Wang Y, Du X, Hutchinson MR, Zhao H, Fang L, Wang X. The pharmacology and therapeutic role of cannabidiol in diabetes. Exploration (Beijing). 2023 Jul 12;3(5):20230047. doi: 10.1002/EXP.20230047. PMID: 37933286; PMCID: PMC10582612.
